[HTML][HTML] Combined radiotherapy and anti–PD-L1 antibody synergistically enhances antitumor effect in non–small cell lung cancer

X Gong, X Li, T Jiang, H Xie, Z Zhu, F Zhou… - Journal of Thoracic …, 2017 - Elsevier
Introduction Immune escape frequently occurs and restricts the durability of the antitumor
immune response to radiotherapy. Programmed death 1 (PD-1) and programmed death …

Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer

X Gong, X Li, T Jiang, H Xie, Z Zhu… - Journal of thoracic …, 2017 - pubmed.ncbi.nlm.nih.gov
Introduction Immune escape frequently occurs and restricts the durability of the antitumor
immune response to radiotherapy. Programmed death 1 (PD-1) and programmed death …

Combined Radiotherapy and Anti-PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non-Small Cell Lung Cancer.

X Gong, X Li, T Jiang, H Xie, Z Zhu, F Zhou… - Journal of Thoracic …, 2017 - europepmc.org
Methods The role of the phosphoinositide 3-kinase/protein kinase B signal transducer and
activator of transcription 3, epithelial-mesenchymal transition, and tripartite motif containing …

[引用][C] Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer

X Gong, X Li, T Jiang, H Xie, Z Zhu, F Zhou… - Journal of Thoracic …, 2017 - cir.nii.ac.jp
Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect
in Non–Small Cell Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …

[HTML][HTML] Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer

X Gong, X Li, T Jiang, H Xie, Z Zhu, F Zhou… - Journal of Thoracic …, 2017 - jto.org
Introduction Immune escape frequently occurs and restricts the durability of the antitumor
immune response to radiotherapy. Programmed death 1 (PD-1) and programmed death …